Chitotriosidase, a Marker of Innate Immunity, Is Elevated in Patients With Primary Breast Cancer

Cancer Biomarkers - Netherlands
doi 10.3233/cbm-160101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

Collagen IV Levels Are Elevated in the Serum of Patients With Primary Breast Cancer Compared to Healthy Volunteers

British Journal of Cancer
Cancer ResearchOncology
2008English

Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Circulating Tumour Cell-Derived Plastin3 Is a Novel Marker for Predicting Long-Term Prognosis in Patients With Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Serum HER-2 Concentration in Patients With Primary Breast Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Publisher Correction: Harnessing Innate Immunity in Cancer Therapy

Nature
Multidisciplinary
2019English

Excision of the Primary Tumour in Patients With Metastatic Breast Cancer: A Clinical Dilemma

Current Oncology
Oncology
2012English

ERR Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Serum Expression of Β-Catenin Is a Potential Detection Marker in Patients With Colorectal Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy